SCHEMBL9823508

SCHEMBL9823508

C#CCN(Cc1ccc2nc(N)[nH]c(=O)c2c1)c1ccc(C(=O)NCCN(CC)CC)cc1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 7/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9823465 0.88 DHFR (0.75) DHFR
SCHEMBL9823610 0.87 DHFR (0.74) DHFR
SCHEMBL18402522 0.87 DHFR (0.72) DHFR
SCHEMBL9808429 0.87
SCHEMBL9823100 0.86 DHFR (0.53) DHFR
SCHEMBL20094841 0.86 DHFR (0.70) DHFR
SCHEMBL9823269 0.84 DHFR (1.00) DHFR
SCHEMBL31490169 0.84 DHFR (0.87) DHFR
SCHEMBL7263046 0.84 DHFR (0.87) DHFR
SCHEMBL9808433 0.83 TYMS (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426666-A1 SUBSTITUTED QUINAZOLINONES AS ANTICANCER AGENTS WARNER-LAMBERT COMPANY (US) 1991-05-15 EP disclosed
US-4857530-A THYMIDYLATE SYNTHASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-08-15 US disclosed
EP-0316657-A1 Substituted quinazolinones as anticancer agents WARNER-LAMBERT COMPANY (US) 1989-05-24 EP disclosed
WO-1989004307-A1 SUBSTITUTED QUINAZOLINONES AS ANTICANCER AGENTS WARNER-LAMBERT COMPANY (US) 1989-05-18 WO disclosed